292 related articles for article (PubMed ID: 30444190)
1. MicroRNA Regulation of Energy Metabolism to Induce Chemoresistance in Cancers.
Ye J; Zou M; Li P; Liu H
Technol Cancer Res Treat; 2018 Jan; 17():1533033818805997. PubMed ID: 30444190
[TBL] [Abstract][Full Text] [Related]
2. How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Icard P; Shulman S; Farhat D; Steyaert JM; Alifano M; Lincet H
Drug Resist Updat; 2018 May; 38():1-11. PubMed ID: 29857814
[TBL] [Abstract][Full Text] [Related]
3. Autophagy-mediating microRNAs in cancer chemoresistance.
Jing Y; Liang W; Liu J; Zhang L; Wei J; Yang J; Zhang Y; Huang Z
Cell Biol Toxicol; 2020 Dec; 36(6):517-536. PubMed ID: 32875398
[TBL] [Abstract][Full Text] [Related]
4. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
5. Critical role of HMGA proteins in cancer cell chemoresistance.
D'Angelo D; Mussnich P; Arra C; Battista S; Fusco A
J Mol Med (Berl); 2017 Apr; 95(4):353-360. PubMed ID: 28293697
[TBL] [Abstract][Full Text] [Related]
6. Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics.
Allen KE; Weiss GJ
Mol Cancer Ther; 2010 Dec; 9(12):3126-36. PubMed ID: 20940321
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity.
Ashrafizadeh M; Zarrabi A; Orouei S; Kiavash Hushmandi ; Hakimi A; Amirhossein Zabolian ; Daneshi S; Samarghandian S; Baradaran B; Najafi M
Eur J Pharmacol; 2021 Feb; 892():173660. PubMed ID: 33310181
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
[TBL] [Abstract][Full Text] [Related]
9. Find new channel for overcoming chemoresistance in cancers: Role of stem cells-derived exosomal microRNAs.
Hussein GM; Mohammed SM; Faris M; Mohammed A; Kadhim MJ; Awadh SA; Ajam WH; Jalil AT
Int J Biol Macromol; 2022 Oct; 219():530-537. PubMed ID: 35948201
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.
Hamano R; Miyata H; Yamasaki M; Kurokawa Y; Hara J; Moon JH; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
Clin Cancer Res; 2011 May; 17(9):3029-38. PubMed ID: 21248297
[TBL] [Abstract][Full Text] [Related]
12. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
[TBL] [Abstract][Full Text] [Related]
13. Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity.
Sharma A
Nanomedicine (Lond); 2017 Sep; 12(17):2137-2148. PubMed ID: 28805111
[TBL] [Abstract][Full Text] [Related]
14. The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance.
Zhao L; Liu W; Xiao J; Cao B
Cancer Lett; 2015 Jan; 356(2 Pt B):339-46. PubMed ID: 25449429
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene.
Sun X; Lou L; Zhong K; Wan L
Exp Biol Med (Maywood); 2017 Jun; 242(12):1299-1305. PubMed ID: 28429654
[TBL] [Abstract][Full Text] [Related]
16. Role of microRNAs in remodeling the tumor microenvironment (Review).
Pan Z; Tian Y; Niu G; Cao C
Int J Oncol; 2020 Feb; 56(2):407-416. PubMed ID: 31894326
[TBL] [Abstract][Full Text] [Related]
17. The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6.
Yin Y; Yao S; Hu Y; Feng Y; Li M; Bian Z; Zhang J; Qin Y; Qi X; Zhou L; Fei B; Zou J; Hua D; Huang Z
Clin Cancer Res; 2017 Dec; 23(23):7375-7387. PubMed ID: 28928161
[No Abstract] [Full Text] [Related]
18. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
19. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-induced drug resistance in gastric cancer.
Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
